help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on July 24, 2007
Molecular Endocrinology, doi:10.1210/me.2006-0473
A more recent version of this article appeared on November 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
21/11/2775    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yu, J.
Right arrow Articles by Barker, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, J.
Right arrow Articles by Barker, C. J.

Submitted on November 13, 2006
Accepted on July 20, 2007

AN AUTOCRINE INSULIN-FEEDBACK LOOP MAINTAINS PANCREATIC {beta}-CELL 3-PHOSPHORYLATED INOSITOL LIPIDS

Jia Yu, Per-Olof Berggren*, and Christopher J. Barker

The Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Karolinska University Hospital Solna, SE-171 76, Stockholm, Sweden

* To whom correspondence should be addressed. E-mail: per-olof.berggren{at}ki.se.

Phosphatidylinositol 3-kinases (PI3Ks) have a central role in pancreatic {beta}-cell function. Downstream events include the regulation of KATP channel activity, insulin secretion, gene transcription and cell survival. Less data are available on the 3-phosphorylated inositol lipids (3-PI's) that are the primary products of these kinases. We characterized these PI3K-products in insulin secreting HIT-T15 cells and were able to demonstrate, for the first time, the presence of phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2). We then showed that glucose can significantly increase PtdIns(3,4,5)P3, PtdIns(3,4)P2 and notably PtdIns(3,5)P2. We investigated the mechanism(s) whereby these molecules are generated under both basal and glucose-stimulated conditions. We postulated that insulin exocytosis could drive the rises in 3-PI's. In our experimental system we could detect a rise in insulin secretion within 1 minute of glucose stimulation, thus allowing the possibility that early rises in 3-PIs are regulated by secreted insulin. This was confirmed as blockade of the {beta}-cell insulin receptor completely abrogated the glucose-mediated increase of all three lipids, driving their concentrations below basal levels. Using primary pancreatic islets and either blockade of the insulin receptor or antibodies to insulin we verified that basal insulin secretion is responsible for the maintenance of 3-PIs. Therefore, autocrine insulin signaling, a feature compromised in diabetes, is essential to upregulate both basal and glucose-stimulated levels of a vital family of second messengers that preserve and drive pancreatic {beta}-cell function.


Key words: Phosphatidylinositol 3 • 5-bisphosphate • Phosphatidylinositol 3 • 4 • 5-trisphosphate • pancreatic beta cell • PI-3 kinase • insulin secretion







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society